Early Stage Biotech

Richard shares his journey from business to biotech consulting, emphasizing the critical nature of early-stage investments. He explains how the focus shifts from clinical data in later stages to strategic planning and technology application at the seed and Series A levels. This approach is essential for guiding nascent companies toward successful funding and clinical trials.